Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
With a market cap of 12.2B, Corcept Therapeutics(CORT) trades at $112.80. The stock has a price-to-earnings ratio of 263.74.
As of 2026-09-04, Corcept Therapeutics(CORT) stock has fluctuated between $109.43 and $114.61. The current price stands at $112.80, placing the stock +3.1% above today's low and -1.6% off the high.
Corcept Therapeutics(CORT) shares are trading with a volume of 588.71K, against a daily average of 851.33K.
In the last year, Corcept Therapeutics(CORT) shares hit a 52-week high of $126.38 and a 52-week low of $28.66.
In the last year, Corcept Therapeutics(CORT) shares hit a 52-week high of $126.38 and a 52-week low of $28.66.
CORT News
...
New insider activity at Corcept Therapeutics ( (CORT) ) has taken place on August 28, 2026. Director Park Kimberly has recently cashed out a significant portion...
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.